University of Michigan
Ann Arbor, Michigan, United States
Dr. Oldham is an Associate Professor at the University of Michigan, where he leads clinical and translational interstitial lung disease (ILD) research. He completed his medical training at the University of Colorado, internal medicine residency at UC-Davis and pulmonary and critical care fellowship at the University of Chicago. He is currently funded by the NHLBI to conduct high-throughput proteomics investigation and develop composite protein biomarkers to predict clinically relevant endpoints in patients with fibrotic ILD.
Monday, October 27, 2025
1:00 PM – 1:30 PM Central Time
Disclosure(s): Boehringer-Ingelheim: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Roche: Consultant (Ongoing)
